These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12902984

  • 1. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.
    Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S.
    Oncogene; 2003 Aug 07; 22(32):5011-20. PubMed ID: 12902984
    [Abstract] [Full Text] [Related]

  • 2. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.
    Sugiura H, Toyama T, Hara Y, Zhang Z, Kobayashi S, Fujii Y, Iwase H, Yamashita H.
    Jpn J Clin Oncol; 2007 Nov 07; 37(11):820-8. PubMed ID: 17932113
    [Abstract] [Full Text] [Related]

  • 3. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.
    J Mol Endocrinol; 2005 Apr 07; 34(2):553-66. PubMed ID: 15821116
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 5. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK, Kapucuoğlu N.
    Pathol Res Pract; 2012 Mar 15; 208(3):133-9. PubMed ID: 22336175
    [Abstract] [Full Text] [Related]

  • 6. Wild-type estrogen receptor (ERbeta1) and the splice variant (ERbetacx/beta2) are both expressed within the human endometrium throughout the normal menstrual cycle.
    Critchley HO, Henderson TA, Kelly RW, Scobie GS, Evans LR, Groome NP, Saunders PT.
    J Clin Endocrinol Metab; 2002 Nov 15; 87(11):5265-73. PubMed ID: 12414901
    [Abstract] [Full Text] [Related]

  • 7. Increased estrogen receptor betacx expression during mammary carcinogenesis.
    Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA, Rochefort H.
    Clin Cancer Res; 2005 May 01; 11(9):3170-4. PubMed ID: 15867209
    [Abstract] [Full Text] [Related]

  • 8. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N, Jansson D, Mader S, Pratt MA.
    J Cell Biochem; 2009 Jun 01; 107(3):448-59. PubMed ID: 19350539
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ, Monroe DG, Dutta S, Ingle JN, Spelsberg TC.
    J Cell Biochem; 2007 Aug 01; 101(5):1125-47. PubMed ID: 17520659
    [Abstract] [Full Text] [Related]

  • 10. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
    Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O.
    Breast Cancer Res Treat; 2008 Aug 01; 110(3):507-20. PubMed ID: 17876701
    [Abstract] [Full Text] [Related]

  • 11. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
    Neubauer H, Ruoff A, Paessler N, Solomayer E, Wallwiener D, Fehm T.
    Oncol Rep; 2009 Feb 01; 21(2):475-81. PubMed ID: 19148525
    [Abstract] [Full Text] [Related]

  • 12. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Lattrich C, Juhasz-Boess I, Ortmann O, Treeck O.
    Oncol Rep; 2008 Mar 01; 19(3):811-7. PubMed ID: 18288420
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
    Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S.
    Cancer Chemother Pharmacol; 2003 Jul 01; 52 Suppl 1():S34-8. PubMed ID: 12819932
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC.
    J Cell Biochem; 2003 Oct 01; 90(2):315-26. PubMed ID: 14505348
    [Abstract] [Full Text] [Related]

  • 15. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 17. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA, Thompson LU.
    Breast Cancer Res Treat; 2003 Oct 01; 81(3):209-21. PubMed ID: 14620916
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 01; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 19. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.
    J Cell Physiol; 2004 Sep 01; 200(3):440-50. PubMed ID: 15254972
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
    Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):692-9. PubMed ID: 11726203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.